Thursday, February 2, 2023

 

Bulk Drug Substances Currently Under Review - FDA

Bulk Drug Substance (BDS)SpeciesNomination
Acepromazine maleatedog, cat, horseFDA‑2018‑N‑4626‑0114
Acetyl‑D‑glucosaminedog, horseFDA‑2018‑N‑4626‑0104
Actinomycin Ddog, catFDA‑2018‑N‑4626‑0106

No comments: